Critical Care · 2008 · 41 citations · 23 references
Veterinary MedicineImmunologyPharmacologyInflammationInnate ImmunitySepsisAcute InflammationAcute Lung InjuryAnti-inflammatory PharmacologyCytokine BiologyInflammatory MediatorsSepsis PathophysiologyAcute Lung Injury PathophysiologyCytokine-mediated Lung InjuryEndotoxin-mediated InflammationHigh-mobility Group Box 1 SignalingSepsis-associated Cytokine ResponseSepsis-associated InflammationSepsis-associated Lung InjurySepsis-induced Tissue Injury
INTRODUCTION: Systemic inflammatory mediators, including high mobility group box 1 (HMGB1), play an important role in the development of sepsis. Anticoagulants, such as danaparoid sodium (DA), may be able to inhibit sepsis-induced inflammation, but the mechanism of action is not well understood. We hypothesised that DA would act as an inhibitor of systemic inflammation and prevent endotoxin-induced acute lung injury in a rat model. METHODS: We used male Wistar rats. Animals in the intervention arm received a bolus of 50 U/kg of DA or saline injected into the tail vein after lipopolysaccharide (LPS) administration. We measured cytokine (tumour necrosis factor (TNF)alpha, interleukin (IL)-6 and IL-10) and HMGB1 levels in serum and lung tissue at regular intervals for 12 h following LPS injection. The mouse macrophage cell line RAW 264.7 was assessed following stimulation with LPS alone or concurrently with DA with identification of HMGB1 and other cytokines in the supernatant. RESULTS: Survival was significantly higher and lung histopathology significantly improved among the DA (50 U/kg) animals compared to the control rats. The serum and lung HMGB1 levels were lower over time among DA-treated animals. In the in vitro study, administration of DA was associated with decreased production of HMGB1. In the cell signalling studies, DA administration inhibited the phosphorylation of IkappaB. CONCLUSION: DA decreases cytokine and HMGB1 levels during LPS-induced inflammation. As a result, DA ameliorated lung pathology and reduces mortality in endotoxin-induced systemic inflammation in a rat model. This effect may be mediated through the inhibition of cytokines and HMGB1.
23
The Acute Respiratory Distress Syndrome
Lorraine B. Ware, Michael A. Matthay · New England Journal of Medicine · 2000 · 4.7K citations
Medicine, Pathobiology, Pathology +17
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Haichao Wang, Ona Bloom, Minghuang Zhang et al. · Science · 1999 · 3.4K citations
IL-10 inhibits cytokine production by activated macrophages
David Fiorentino, Albert Zlotnik, Tim R. Mosmann et al. · The Journal of Immunology · 1991 · 2.9K citations · Full text
Macrophage deactivation by interleukin 10.
Christian Bogdan, Yoram Vodovotz, Carl Nathan · The Journal of Experimental Medicine · 1991 · 1.2K citations · Full text
Proteinase-activated Receptors
Scott R. Macfarlane, Michael J. Seatter, Toru Kanke et al. · 2006 · 1.1K citations